Company Valuation: ResMed Inc.

Data adjusted to current consolidation scope
Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 30,691 32,133 28,117 37,762 28,145 31,638 - -
Change - 4.7% -12.5% 34.31% -25.47% 12.41% - -
Enterprise Value (EV) 1 31,192 33,346 28,585 37,221 27,335 30,684 30,026 29,319
Change - 6.9% -14.28% 30.21% -26.56% 12.25% -2.14% -2.35%
P/E 39.6x 35.9x 27.7x 27.1x 18.7x 19x 17.3x 15.7x
PBR 9.35x 7.76x 5.78x 6.33x 4.27x 4.57x 4.11x 4.21x
PEG - 2.4x 2x 0.7x 1.93x 1.6x 1.77x 1.6x
Capitalization / Revenue 8.58x 7.61x 6x 7.34x 4.98x 5.45x 5.13x 4.79x
EV / Revenue 8.72x 7.9x 6.1x 7.23x 4.84x 5.28x 4.87x 4.44x
EV / EBITDA 26.8x 25.3x 18.1x 19.8x 11.7x 13.6x 12.4x 11.4x
EV / EBIT 31.2x 27.2x 19.3x 21.1x 13.4x 14.7x 13.3x 12.1x
EV / FCF 144x 58.1x 22x 22.4x 16.6x 18.6x 16.8x 15.4x
FCF Yield 0.69% 1.72% 4.55% 4.46% 6.03% 5.37% 5.94% 6.5%
Dividend per Share 2 1.68 1.8 1.92 2.12 2.46 2.66 2.931 3.207
Rate of return 0.8% 0.82% 1% 0.82% 1.26% 1.2% 1.33% 1.45%
EPS 2 5.3 6.09 6.92 9.51 10.43 11.63 12.77 14.05
Distribution rate 31.7% 29.6% 27.7% 22.3% 23.6% 22.9% 23% 22.8%
Net sales 1 3,578 4,223 4,685 5,146 5,653 5,806 6,171 6,601
EBITDA 1 1,162 1,317 1,576 1,884 2,329 2,250 2,419 2,579
EBIT 1 1,000 1,224 1,478 1,763 2,039 2,089 2,260 2,420
Net income 1 779.4 897.6 1,021 1,401 1,523 1,642 1,782 1,917
Net Debt 1 501.5 1,213 468.9 -541.2 -809.9 -954.7 -1,613 -2,320
Reference price 2 209.63 218.50 191.42 258.00 194.88 221.15 221.15 221.15
Nbr of stocks (in thousands) 146,405 147,062 146,884 146,365 144,421 143,062 - -
Announcement Date 8/11/22 8/3/23 8/1/24 7/31/25 8/6/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
33.55x5.86x22.46x0.27% 250B
37.53x6.7x21.23x0.64% 156B
44.07x11.66x25.74x-.--% 144B
16.51x3.39x11.05x-.--% 63.26B
34.11x6.82x21.58x-.--% 49.75B
33.56x6.64x22.54x0.6% 48.58B
18.65x2.28x11.55x2.7% 47.99B
43.7x10.61x23.39x-.--% 46.22B
76.92x7.32x22.3x-.--% 43.17B
Average 37.62x 6.81x 20.20x 0.47% 94.22B
Weighted average by Cap. 36.74x 7.04x 21.32x 0.38%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield